Sigma Planning Corp Sells 18,972 Shares of Astera Labs, Inc. $ALAB

Sigma Planning Corp reduced its position in Astera Labs, Inc. (NASDAQ:ALAB) by 82.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 3,918 shares of the company’s stock after selling 18,972 shares during the quarter. Sigma Planning Corp’s holdings in Astera Labs were worth $652,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares in the last quarter. State Street Corp boosted its holdings in shares of Astera Labs by 9.1% in the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after buying an additional 195,992 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Astera Labs by 46.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after buying an additional 479,360 shares in the last quarter. Amundi boosted its holdings in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Finally, Value Aligned Research Advisors LLC boosted its holdings in shares of Astera Labs by 16.7% in the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after buying an additional 197,320 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00. Following the completion of the sale, the general counsel directly owned 118,084 shares in the company, valued at $12,725,912.68. This trade represents a 7.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This trade represents a 36.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,064,888 shares of company stock valued at $150,764,723 over the last 90 days. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Up 7.2%

ALAB stock opened at $215.69 on Wednesday. The firm has a 50 day moving average of $140.72 and a 200 day moving average of $153.38. The stock has a market capitalization of $36.94 billion, a PE ratio of 176.80, a price-to-earnings-growth ratio of 3.96 and a beta of 3.35. Astera Labs, Inc. has a 52 week low of $63.40 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period last year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ALAB shares. Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday. They issued a “neutral” rating and a $153.00 price target on the stock. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Barclays set a $165.00 price target on shares of Astera Labs in a report on Thursday, January 15th. Stifel Nicolaus set a $236.00 price target on shares of Astera Labs in a report on Friday. Finally, Citigroup initiated coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They issued a “buy” rating and a $200.00 target price for the company. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $199.20.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 earnings and revenue beat consensus — EPS $0.61 vs. $0.54 est.; revenue $308.4M, up 93% year-over-year and above expectations, showing rapid top-line expansion. Astera Labs Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised Q2 (FY26 Q2) guidance sharply — EPS guide of $0.680–0.700 vs. street ~$0.50 and revenue guidance ~$355–365M vs. ~$310M consensus, implying continued acceleration into the quarter. Q1 Press Release / Guidance
• Positive Sentiment: Company points to AI spending as a key growth driver and raised investor expectations that demand from hyperscalers and AI customers is sustaining strong order flow. Astera Labs jumps as AI spending buoys Q1 results, guidance
• Positive Sentiment: Product traction: new Scorpio X?Series 320?lane smart fabric switch now shipping to leading hyperscalers, supporting the company’s positioning in rack?scale AI connectivity. Scorpio X-Series Product Release
• Positive Sentiment: Third?party sentiment and coverage supportive — analysts have an average “Moderate Buy” and prominent commentators (e.g., Jim Cramer) publicly bullish ahead of/around the report, reinforcing investor interest. Analyst Rating Jim Cramer Comment
• Neutral Sentiment: Sector tailwinds: broader chip/semiconductor stocks rallied recently, which likely amplified the stock’s move as investors rotated into AI- and infrastructure-exposed names. Chip Stocks Rally

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.